Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001823 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation for NCI Surgery Branch Clinical Research Protocols

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 344 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. New version filed on ClinicalTrials.gov
  3. 48 versions Re-verified since Feb 12, 2025, no change to tracked fieldsv295-v342
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Cancer Institute (NCI)
961 trials monitored
See 68 trials at risk
Lung Cancer
4,057 trials monitored
See 218 trials at risk
Colorectal Cancer
2,920 trials monitored
See 134 trials at risk
Melanoma
1,026 trials monitored
See 48 trials at risk
and 1 more disease
Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.
Trial Details
NCT Number NCT00001823
Lead Sponsor National Cancer Institute (NCI)
Conditions Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
Enrollment 7,000 participants
Start Date
Updated on ClinicalTrials.gov